Table of Content

Introduction
Executive Summary
Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists: Overview
• CGRP Receptor - Overview
• Structure and Signaling of the CGRP Receptor
• Regulation of Synthesis and Release of CGRP
• CGRP Metabolism
• CGRP Receptor Antagonists
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists
In-depth Commercial Assessment
• Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists companies’ collaborations, Licensing, Acquisition -Deal Value Trends
Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists Collaboration Deals
• Company-Company Collaborations (Licensing / Partnering) Analysis
• Company-University Collaborations (Licensing / Partnering) Analysis
Late Stage Products (Phase III)
• Comparative Analysis
AMG334: Novartis Pharmaceuticals
• Product Description
• Research and Development
• Product Development Activities
Zavegepant: Biohaven Pharmaceuticals, Inc.
• Product Description
• Research and Development
• Product Development Activities
Mid Stage Products (Phase II)
• Comparative Analysis
Erenumab: Amgen / Novartis
• Product Description
• Research and Development
• Product Development Activities
Inactive Products
Comparative Analysis
• Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists Key Companies
• Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists Key Products
• Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists- Unmet Needs
Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists- Market Drivers and Barriers
• Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists- Future Perspectives and Conclusion
• Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists Analyst Views
• Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists Key Companies
Appendix



List of Figures


Figure 1 Total Products for Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products

 

List of Tables


Table 1 Total Products for Calcitonin Gene-related Peptide Receptor (CGPR) Antagonists
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products